Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01847 |
| Species: | Homo sapiens |
| Position : | chr8:128747000-128748000 |
| Year: | 2024 |
| Title: | RUNX1 C-terminal mutations impair blood cell differentiation by perturbing specific enhancer-promoter networks |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | colorectal carcinoma |
| PMID: | 38513139 |
| MONDO: | MONDO:0005132 |
| Tissue: | Colon |
| Tissue Ontology ID: | UBERON:0001155 |
| Cell Source: | HCT116 |
| CVCL ID: | CVCL_0291 |
| Cell Type: | colorectal carcinoma cell |
| Cell Ontology ID: | CL:0000066 |
| Experiment Type: | Enhancer activity assay, TF binding assay, Chromatin interaction assay, Functional perturbation assay |
| High Throughput Method: | ChIP-seq, GRID-seq, RNA-seq |
| Low Throughput Method: | CUT&RUN-RT-qPCR, shRNA Knockdown, RT-RT-qPCR, Western blot |
| Target gene : | MYC |
| TF name : | RUNX1; RUNX1R320*; FOXK2 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_01708 | chr8:126650000-129950000 | Colon | colorectal carcinoma cell | colorectal carcinoma |
| E_01648 | chr8:128740000-128750000 | Blood | chronic myeloid leukemia cell | chronic myeloid leukemia |
| E_01307 | chr8:128747000-128748000 | Blood | chronic myeloid leukemia cell | chronic myeloid leukemia |